You are here

  • Home
  • Archive
  • Volume 28, Issue 3
  • An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian Cancer

Article metrics

Article menu
Download PDFPDF
Ovarian Cancer
An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian Cancer

 

Online download statistics by month:

Online download statistics by month: February 2019 to April 2024

AbstractFullPdf
Feb 2019600
Mar 20198101
Apr 20194200
May 20195301
Jun 20194302
Jul 20194801
Aug 20194400
Sep 20199600
Oct 20194802
Nov 20195900
Dec 20195202
Jan 20207200
Feb 20205100
Mar 20205600
Apr 20202700
May 20202800
Jun 20202603
Jul 20202800
Aug 20202101
Sep 20202600
Oct 20202200
Nov 2020600
Dec 20201200
Jan 20212300
Feb 20211800
Mar 20211801
Apr 20211800
May 2021103
Aug 2021201
Oct 20211500
Nov 20212200
Dec 20211400
Jan 20222200
Feb 2022901
Mar 20223600
Apr 20222200
May 20224600
Jun 20224401
Jul 20225101
Aug 20224601
Sep 20224801
Oct 20223600
Nov 20222801
Dec 20226203
Jan 20231400
Feb 20237402
Mar 20231701
Apr 2023800
May 20231805
Jun 20231001
Jul 20233201
Aug 20232201
Sep 20231401
Oct 20231500
Nov 20232803
Dec 20232600
Jan 20242800
Feb 20241602
Mar 20242600
Apr 20241400
Total1890044